NEW YORK, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Wealthfront Corporation (NASDAQ: WLTH) for potential violations of the federal securities laws. If you invested in Wealthfront, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/wealthfront-corporation-class-action. Why is Wealthfront Being Investigated for Violations of the Federal Securities Laws? Wealthfront is an online financial ...

Partner Reed Kathrein Scrutinizing ZBH's "High Confidence" Assurances After 15% Stock Collapse and Reduced Revenue Guidance SAN FRANCISCO, Jan. 27, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman is investigating Zimmer Biomet Holdings, Inc. (NYSE: ZBH) following a series of disclosures that calls into question the reasonable basis for the company's previously expressed "high confidence" in its 2025 revenue targets. The firm urges investors who suffered significant losses to submit ...

Company Overview - Anavex Life Sciences Corp. is a clinical-stage biotech company focused on developing targeted therapies for neurodegenerative and CNS disorders, including Alzheimer's and Parkinson's disease [3]. Allegations and Stock Impact - Anavex is under investigation for potential violations of federal securities laws due to allegations of providing misleading business information to investors [1]. - On November 14, 2025, Anavex announced an unfavorable preliminary opinion from the Committee for Medicinal Products for Human Use (CHMP) regarding its marketing application for blarcamesine, leading to a significant stock price drop of $2.05 per share, or 35.94%, closing at $3.65 per share on the same day [4].

Core Viewpoint - A securities class action lawsuit has been filed against Coupang, Inc. due to a significant data breach and alleged delays in disclosure, which have negatively impacted the company's stock price [1][2]. Group 1: Lawsuit Details - The lawsuit seeks to represent investors who acquired Coupang securities between August 6, 2025, and December 16, 2025 [1][4]. - The lead plaintiff deadline for the lawsuit is set for February 17, 2026 [4]. - The lawsuit questions whether Coupang misled investors regarding the adequacy of its cybersecurity protocols and the timeliness of its disclosures related to cybersecurity incidents [4]. Group 2: Data Breach Incident - Coupang experienced a data breach affecting approximately 33.7 million customers, which was reported on November 30, 2025 [5]. - The breach was attributed to a former employee who retained access credentials after leaving the company in 2024 [7]. - Coupang first detected the breach on November 18, 2025, and subsequently faced scrutiny from South Korean authorities [6][8]. Group 3: Financial Impact - Since the breach was reported, Coupang's market capitalization has decreased by over $8 billion [9]. - The company warned of potential material financial losses due to revenue loss and increased expenses, including regulatory penalties [8].

Core Viewpoint - A securities class action lawsuit has been filed against Coupang, Inc. due to a significant data breach and alleged delays in disclosure, leading to a substantial decline in the company's stock price [1][2]. Group 1: Lawsuit Details - The lawsuit, Barry v. Coupang, Inc., seeks to represent investors who acquired Coupang securities between August 6, 2025, and December 16, 2025 [1][4]. - The lead plaintiff deadline for the lawsuit is set for February 17, 2026 [4]. Group 2: Data Breach Incident - Coupang experienced a data breach affecting approximately 33.7 million customers, which was reported on November 30, 2025 [5]. - The breach was attributed to a former employee who retained access credentials after leaving the company in 2024 [7]. - Coupang first detected the breach on November 18, 2025, and subsequently confirmed the incident in an interim report filed on December 16, 2025 [8]. Group 3: Financial Impact - Since the breach was reported, Coupang has lost over $8 billion in market capitalization [9]. - The company warned of potential material financial losses due to revenue loss and increased expenses, including regulatory penalties [8]. Group 4: Company Background - Coupang provides a range of services including retail, restaurant delivery, video streaming, and fintech under various brands [4]. - The company has emphasized its commitment to cybersecurity, claiming to have built capabilities to securely transmit sensitive information [4].

New York, New York--(Newsfile Corp. - December 22, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Jefferies Financial Group Inc. (NYSE: JEF) and Point Bonita Capital for potential violations of the federal securities laws after SEC probe is revealed.If you invested in Jefferies or Point Bonita, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/jefferies-financial-group-inc-class-action.Why are Jefferies and Point Bo ...

Core Viewpoint - Johnson Fistel, PLLP has initiated an investigation into board members and executive officers of Compass Diversified Holdings for potential breaches of fiduciary duties and violations of federal securities laws [1]. Group 1: Investigation Details - A class action complaint was filed against Compass Diversified Holdings, alleging that from May 1, 2024, to May 7, 2025, the defendants made false and misleading statements and failed to disclose that the company had overstated the financial performance and stability of its portfolio companies [2]. - The complaint claims that the defendants' positive statements regarding CODI's business, operations, and prospects were materially false and misleading and lacked a reasonable basis [2]. Group 2: Stockholder Rights - Current stockholders who held their Compass Diversified Holdings stock before March 1, 2025, are encouraged to contact Johnson Fistel to discuss their legal rights in this matter [3].

Core Viewpoint - The complaint against CTO Realty Growth alleges violations of federal securities laws, including misleading statements about the sustainability of dividends and the true profitability of its properties, leading to an overstatement of the company's financial prospects [2][3]. Group 1: Allegations and Financial Practices - The complaint claims that CTO's dividends were less sustainable than represented, and the company used deceptive practices to inflate its Adjusted Funds From Operations (AFFO) [2]. - Wolfpack Research's report criticized CTO for not generating sufficient cash to cover recurring capital expenditures and dividends since its conversion to a REIT in 2021, relying instead on share dilution [3]. - The report highlighted that CTO increased its shares outstanding by 70% since December 2022 to cover a $38 million dividend shortfall from 2021 to 2024, and employed a manipulative definition of AFFO that excluded recurring capital expenditures [3]. Group 2: Financial Position and Market Reaction - As of the report, CTO had only $8.4 million in cash while facing quarterly dividends of $14 million and average recurring capital expenditures of $5.7 million, along with additional planned capital expenditures of approximately $12 million [3]. - Following the release of the Wolfpack Report, CTO's stock price fell by $0.98 per share, or 5.42%, closing at $17.10 per share on June 25, 2025 [4].

Core Viewpoint - Semler Scientific Inc. is under investigation for potential violations of federal securities laws and unlawful business practices, particularly concerning its QuantaFlo device reimbursement claims [1][2]. Company Summary - Semler filed its Form 10-K with the SEC on February 28, 2025, revealing an initial civil investigative demand from the U.S. Department of Justice (DOJ) dating back to July 2017 [2]. - The company has faced multiple requests for information from the DOJ, with significant dates including February 2019, December 2021, April 2022, and April 2023 [2]. - Settlement discussions with the DOJ in February 2025 were unsuccessful, leading to concerns that the DOJ may file a civil False Claims Act lawsuit against Semler [2]. - Following the news of the investigation, Semler's share price dropped from $42.92 to $38.89, a decline of $4.03 per share, between February 28 and March 3, 2025 [2]. Legal Context - Bragar Eagel & Squire, P.C. is investigating potential claims on behalf of Semler stockholders regarding the company's legal issues [1]. - The law firm specializes in representing investors in complex litigation, including securities and derivative cases [4].

Core Viewpoint - The U.S. Department of Justice has filed a False Claims Act complaint against SelectQuote and other health insurance companies, alleging illegal kickbacks related to Medicare Advantage plans, leading to a significant drop in SelectQuote's stock price [2]. Group 1: Legal Investigation - Bragar Eagel & Squire, P.C. is investigating potential claims against SelectQuote on behalf of its stockholders for possible violations of federal securities laws and unlawful business practices [1]. - The DOJ's complaint alleges that from 2016 to at least 2021, SelectQuote and other insurers paid hundreds of millions of dollars in illegal kickbacks to brokers for enrollments in Medicare Advantage plans [2]. Group 2: Stock Market Impact - Following the announcement of the DOJ lawsuit, SelectQuote's stock price decreased by $0.61 per share, representing a 19.24% decline, closing at $2.56 per share on May 1, 2025 [2].